BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 191 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2019. The put-call ratio across all filers is 0.20 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,178,000 | -85.1% | 40,000 | -88.6% | 0.42% | -88.8% |
| Q3 2019 | $14,602,000 | +233.5% | 350,000 | +250.0% | 3.72% | +309.7% |
| Q2 2019 | $4,379,000 | -51.4% | 100,000 | -42.9% | 0.91% | -61.4% |
| Q1 2019 | $9,007,000 | -11.4% | 175,000 | -36.4% | 2.35% | -36.3% |
| Q4 2018 | $10,170,000 | +35.4% | 275,000 | +37.5% | 3.69% | +131.3% |
| Q3 2018 | $7,510,000 | +6055.7% | 200,000 | +9900.0% | 1.60% | +4333.3% |
| Q2 2018 | $122,000 | -99.2% | 2,000 | -99.7% | 0.04% | -98.9% |
| Q1 2018 | $16,103,000 | +222.6% | 625,100 | +237.9% | 3.26% | +178.4% |
| Q4 2017 | $4,991,000 | – | 185,000 | – | 1.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |